ArteraAI
PrivateLast Round
VC Round
Feb 1, 2024
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ArteraAI is a precision medicine company that develops AI-enabled predictive and prognostic cancer tests to personalize therapy for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArteraAI Comparables
Compare ArteraAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valar Labs | 79% | |
| Avenda Health | 74% | |
| Nanostics Inc. | 73% |
ArteraAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 1, 2024 | ||||
| VC Round | Mar 21, 2023 |
Key People
Founding team and executive leadership
ArteraAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | VC Round |
| TIME Ventures | VC Round |
| Koch-ventures.com | VC Round |
| EDBI | VC Round |
| A&E Investments | VC Round |
| Walden Catalyst | VC Round |
| Koch Disruptive Technologies | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 60% MoM.
- Dec 9, 2025
Launched ArteraAI Prostate Test (Post-RP) for biochemical recurrence.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
Artera Inc. had revenue of $34.3M on Sep 1st '25.
- recognized_asJul 10, 2026
Esteva at Artera recognized as Global Innovator.
ArteraAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ArteraAI's valuation, stock price, and market status.
Is Artera a public or private company?
Artera is a private company.
What is the current stock price of Artera?
Artera is a private company with no public stock price. No recent secondary market data is available.
How much is Artera worth (valuation)?
Valuation information for Artera is not publicly available.
Can I buy Artera stock?
Artera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Artera's last funding round?
Artera's most recent funding round was VC Round on February 1, 2024.
Who are the main investors in Artera?
Key investors in Artera include TIME Ventures, EDBI, Koch Disruptive Technologies, Aramco Ventures, Factory.
Will Artera IPO soon?
No public IPO plans have been announced for Artera.
How can I track Artera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Artera's secondary market activity and sign up for updates.